Two Sigma Investments
ALXN

Two Sigma Investments’s Alexion Pharmaceuticals ALXN Stock Holding History

Two Sigma Investments’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-2,000
Closed -$224K – 3740
2020
Q2 		$224K Sell
2,000
-35,600
-95% -$3.78M ﹤0.01% 2575
2020
Q1 		$3.38M Buy
+37,600
New +$3.69M 0.03% 689
2019
Q4 		– Sell
-6,400
Closed -$627K – 4114
2019
Q3 		$627K Buy
+6,400
New +$721K ﹤0.01% 2363
2019
Q2 		– Sell
-6,000
Closed -$811K – 3807
2019
Q1 		$811K Hold
6,000
– – ﹤0.01% 1952
2018
Q4 		$584K Buy
+6,000
New +$709K ﹤0.01% 2001
2018
Q3 		– Sell
-16,300
Closed -$2.02M – 3754
2018
Q2 		$2.02M Sell
16,300
-8,800
-35% -$1.03M 0.01% 1609
2018
Q1 		$2.8M Buy
25,100
+19,200
+325% +$2.29M 0.01% 1287
2017
Q4 		$706K Sell
5,900
-20,200
-77% -$2.46M ﹤0.01% 2204
2017
Q3 		$3.66M Buy
26,100
+16,100
+161% +$2.19M 0.01% 964
2017
Q2 		$1.22M Buy
10,000
+3,700
+59% +$431K ﹤0.01% 1776
2017
Q1 		$764K Buy
+6,300
New +$812K ﹤0.01% 2086
2016
Q4 		– Sell
-4,000
Closed -$490K – 3636
2016
Q3 		$490K Buy
+4,000
New +$515K ﹤0.01% 2450
2016
Q2 		– Sell
-10,000
Closed -$1.39M – 3364
2016
Q1 		$1.39M Buy
10,000
+6,000
+150% +$881K 0.01% 1406
2015
Q4 		$763K Buy
+4,000
New +$699K ﹤0.01% 1687
2015
Q3 		– Sell
-4,000
Closed -$723K – 2896
2015
Q2 		$723K Sell
4,000
-6,000
-60% -$1.04M ﹤0.01% 1884
2015
Q1 		$1.73M Buy
+10,000
New +$1.81M 0.01% 1253

Other funds holding ALXN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return

Two Sigma Investments's ALXN Position: Q2 2021 in Review

Two Sigma Investments sold out of Alexion Pharmaceuticals (ALXN) in Q2 2021, closing a stake of 57,783 shares — an estimated $8.84M sold.

Two Sigma Investments first reported a position in ALXN in Q2 2013 and held it in 27 quarters. The position peaked at $91.8M in Q2 2016. 708 funds tracked by Wall St. Rank hold ALXN as of Q2 2021.

  • Two Sigma Investments reported no remaining Alexion Pharmaceuticals position as of Q2 2021 after selling out during the quarter.
  • Two Sigma Investments sold 57,783 Alexion Pharmaceuticals shares in Q2 2021, an estimated $8.84M.
  • Two Sigma Investments first reported a position in Alexion Pharmaceuticals in Q2 2013 and held it in 27 quarters.
  • Two Sigma Investments's Alexion Pharmaceuticals position peaked at $91.8M in Q2 2016.
  • 708 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q2 2021.

Based on Two Sigma Investments's 13F filing for Q2 2021, filed 16 Aug 2021.